Autocruitment.com Website Review

the faster, enhanced way to recruit the right patients for your clinical trials or specialty procedures. guaranteed.. a targeted, direct-to-patient, online marketing platform that recruits and refers new patients for your clinical trials or specialty. autocruitment has developed a targeted, direct-to-patient online marketing platform to recruit, screen and refer patients for clinical trials and specialty procedures (such as medical oncology). by teaming sophisticated algorithms with an automated process, we are transforming the once-difficult and time-consuming challenge of referring  new and additional, quality patients for your specialty autocruitment’s unique web-based patient recruitment software platform uses over 400 digital channels to reach and advertise to the 80% of patients who use the internet to actively search for new treatment options, second opinions or  providers for their medical condition - in your geographical location. the autocruitment platform can be used to refer patients for specialty procedures or online-screen and refer patients for clinical trials. with new patients referred via our patient referral portal or directly into our proprietary technology allows us to advertise online to the correct patient population (e.g brca1 patients) rather than anyone (medical students, physicians etc.) who are simply searching the internet for information and don't have the desired condition. this efforts, increases revenues for hospitals, private practices and cancer centers and decreases recruitment times for clinical trials by and with our pay-per-referral model our service is guaranteed; you only pay for the qualified patients we send. we work with hospitals, private practices, cancer centers, pharmaceutical companies, cros, research centers and biotech companies to increase patient acquisition for specialty procedures and clinical trials in all thera*eutic areas.. 80% of patients use the internet to look up health related information - we send those patients to you.